SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending due to the commencement of volume shipments of its NVIDIA Blackwell Ultra systems, a development sparking bullish sentiment among investors. The community is actively discussing the potential for earnings revisions and a stock re-rating, while also weighing the company's historical compliance issues. Some believe the stock is undervalued with substantial upside, while others remain cautious.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending as social media buzzes with anticipation of a potential short squeeze and speculation around new contracts, especially following news of their technology accelerating passenger processing at Nashville International Airport. The community is closely watching for a breakout, drawing comparisons to Palantir and emphasizing the company's role in AI-driven security solutions. Discussions also highlight the stock's chart setup and potential for significant gains, creating a mix of excitement and high expectations.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's stock is trending amid discussions about its earnings and future growth potential, with some traders citing analyst upgrades and AI integration as reasons for optimism. However, many community members express concerns about market manipulation and the stock's historical performance post-earnings, leading to mixed sentiment and active debate on potential price movements. Some users speculate about the impact of AI competition and the possibility of a turnaround, while others express frustration with the stock's perceived underperformance despite positive results.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending amid a noticeable surge, with community members debating whether it's primed for further gains or an overextended meme stock due for a correction. The stock's movement follows news of Nevada approving Tesla's robotaxi testing, alongside commentary around Elon Musk's leadership and the company's valuation.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is experiencing a surge, with the community actively discussing a potential breakout and analyst day catalysts. Some are attributing the rise to early volume and strength, while others point to the acquisition of Oxford Ionics and potential short squeeze. The community is speculating on price targets and whether to sell or hold.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to community excitement around its potential in treating liver diseases, particularly MASH cirrhosis, and speculation about a possible buyout. Bullish investors express confidence, citing insider ownership and promising data, while also noting a high short interest that could lead to a significant short squeeze. Concerns remain about potential short-term volatility and the need for continued positive developments.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI.X is trending as community members are rolling profits into the coin, anticipating a breakout and a broader meme cycle on the Solana network. The community emphasizes the coin's strong community-driven growth and potential as a culture coin, drawing comparisons to other popular meme coins.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to a recent $20 million stock purchase agreement, sparking significant community discussion around a potential short squeeze and future price targets. The company's small float and high short interest are fueling speculation, while upcoming conference participation is anticipated to bring further news. Community members are actively debating the stock's potential for substantial gains versus the risk of a pullback.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

The stock is trending amid discussions of a potential short squeeze, driven by a new CEO and board changes. Community members are actively debating dip-buying strategies and anticipating further upward momentum, while also watching for potential pullbacks and profit-taking.

QMMM Holdings Ltd. engages in the provision of digital advertising services. It offers interactive design, animation, art-tech and virtual technologies used in commercial campaigns. It has worked with domestic and international banks, real estate developers, amusement parks, international sports apparel, footwear brands, luxury cosmetic products, and international brands. The company was founded by Bun Kwai on July 29, 2022 and is headquartered in Hong Kong.

QMMM Holdings Ltd. - Ordinary Shares - Class A

QMMM Holdings Ltd.

QMMM is trending due to speculation around its potential as a crypto play, drawing comparisons to previous high-flying stocks in the sector. Community chatter suggests the stock's low float and crypto treasury plans are attracting attention, with some anticipating a possible short squeeze. However, some users are wary, viewing it as a potential pump and dump scheme.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?

The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Anika (ANIK) Upgraded to Buy: Here's What You Should Know

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?

Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates

Shares of Anika Therapeutics ($ANIK), which provides early intervention for orthopedic care, slipped 3.39% on Friday, a day after the company’s results fell short of Wall Street estimates even as the retail sentiment stayed cautious.Anika has beaten earnings estimates three times in the last four quarters. For the third quarter, the company posted earnings per share (EPS) of - $0.25, missing the consensus estimate of $0.09. Its net loss widened to $29.9 million from $6.6 million in the year-ago period. The company’s reported revenues of $38.75 million were 7.91% below consensus estimates.It also updated its guidance on its 2024 adjusted earnings before interest, taxes, depreciation and amortization, or Ebitda, expecting it to fall between $16 and $18 million.Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37&nbsp; while maintaining an “Outperform” rating on its stock following the results, The Fly.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=ANIK">reported,</a> citing “weakening OA pain volumes and softer pricing” that collectively drove its more pessimistic outlook.Petusky’s price target is based on the company’s FY25 adjusted EBITDA estimate plus $50M of value it adds for the company’s “two potential needle-mover products” – Cingal and Hyalofast – that have completed “pivotal trials” but are yet to receive regulatory approval, the report added.Retail sentiment has remained ‘neutral’ on the stock even as the message volumes soared into the ‘extremely high’ zone.<figure class="image"><img style="aspect-ratio:1304/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_02_at_1_34_53_AM_d6d50fb11b.png" alt="Screenshot 2024-11-02 at 1.34.53 AM.png" width="1304" height="306"><figcaption>ANIK sentiment meter and message volumes on Nov 1 as of 4:36 pm ET</figcaption></figure>Anika also announced the sale of its Arthrosurface business for $10 million, and said it was actively pursuing the sale of another division, Parcus Medical, as part of its efforts to refocus on its strategy. The sale will “optimize” the company's capital allocation and redouble efforts on its profitable core hyaluronic acid (HA) technology and Regenerative Solutions portfolios.Some users were optimistic about its long-term prospects despite shares being down 27% year-to-date.<stembedurl>https://stocktwits.com/Aigner_Andreas/message/582406016</stembedurl>For updates and corrections, email newsroom@stocktwits.com

he company’s reported revenues of $38.75 million were 7.91% below consensus estimates. | Image source: Pixabay

Retail Investors Remain Cautious After Anika’s Q3 Earnings Misses Estimates

Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37 

Equity

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics PR Newswire WEST BRIDGEWATER, Mass...

Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights

Latest Ratings for ANIK
 DateFirmActionFromTo Mar 2022Stephens & Co.DowngradesOverweightEqual-Weight Nov 2021Stephens & Co.Initiates Coverage OnOverweight Jul 2021UBSInitiates Coverage OnNeutral...

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

ANIK
Anika Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIK News

ANIK Anika Therapeutics Inc.